La Roche-Posay, has partnered with the George Washington University Cancer Center to launch the GW Supportive Oncodermatology Clinic, with the first patients to be seen in mid-May at the GW Medical Faculty Associates. Under the leadership of Adam Friedman, MD, Associate Professor of Dermatology, Residency Program Director, and Director of Translational Research in the Department of Dermatology, the clinic will serve the comprehensive dermatologic needs of cancer patients by addressing the broad range of issues that occur during and after treatment. Furthermore, Dr. Friedman and his team will provide valuable expert skincare advice, educational materials, and La Roche-Posay skincare samples to help alleviate and manage the side effects caused by cancer treatment. This type of oncodermatology program with La Roche-Posay currently exists with many hospitals in Europe under Better Skin Throughout Cancer.

"This is a great example of how academia and industry can partner together in a meaningful way to target a common mission, in this case, to improve both the quality of life of those being treated and managed for all forms of cancer and their ongoing care in collaboration with our colleagues in Oncology," shares Dr. Friedman.

In 1975, La Roche-Posay first formulated products using proprietary Thermal Spring Water that could be used alongside treatment. Since then, La Roche-Posay has become a leading player in the development of products safe enough and formulated for even the most sensitive skin types, testing for tolerance and safety. The proprietary Thermal Spring Water is at the heart of La Roche-Posay skincare products, making the therapeutic ingredient available to all. Through La Roche-Posay's ESKIMO group (European Skin Management in Oncology,) a panel of dermatologists and an oncologist specialized in treating both dermatological problems and cancer analyze and propose appropriate skincare product recommendations for patients receiving either chemotherapy or radiotherapy.

In addition to the physiology of sensitive skin, La Roche-Posay has delved deeply into the psychological effects that the condition has on its sufferers taking into consideration the disabling impact on self-esteem and social activities.